{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:44:51Z","timestamp":1789587891258,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00894-026-06761-0","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T02:23:07Z","timestamp":1779070987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rational design and comparative docking and simulation of modified FLT3 inhibitors: a study on enhanced binding stability and inhibition potency"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0007-5691","authenticated-orcid":false,"given":"Uddalak","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheemanth","family":"Regati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sowdhamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"6761_CR1","unstructured":"Vakiti A, Mewawalla P (2024) Acute myeloid leukemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507875\/. Accessed 20 Feb 2024"},{"issue":"1","key":"6761_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"issue":"0","key":"6761_CR3","doi-asserted-by":"publisher","DOI":"10.36922\/CP025060008","volume":"0","author":"U Das","year":"2025","unstructured":"Das U (2025) Emerging trends and research landscape of the tumor microenvironment in head-and-neck cancer: a comprehensive bibliometric analysis. Cancer Plus 0(0):025060008. https:\/\/doi.org\/10.36922\/CP025060008","journal-title":"Cancer Plus"},{"issue":"3","key":"6761_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5030033","volume":"5","author":"JN Saultz","year":"2016","unstructured":"Saultz JN, Garzon R (2016) Acute myeloid leukemia: A concise review. J Clin Med 5(3):33. https:\/\/doi.org\/10.3390\/jcm5030033","journal-title":"J Clin Med"},{"issue":"22","key":"6761_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225426","volume":"15","author":"JU Kazi","year":"2023","unstructured":"Kazi JU, Al Ashiri L, Purohit R, R\u00f6nnstrand L (2023) Understanding the role of activation loop mutants in drug efficacy for FLT3-ITD. Cancers 15(22):5426. https:\/\/doi.org\/10.3390\/cancers15225426","journal-title":"Cancers"},{"key":"6761_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amolm.2024.100058","volume":"5","author":"U Das","year":"2025","unstructured":"Das U, Chandramouli L, Uttarkar A, Kumar J, Niranjan V (2025) Discovery of natural compounds as novel FMS-like tyrosine kinase-3 (FLT3) therapeutic inhibitors for the treatment of acute myeloid leukemia: an in-silico approach. Aspects Mol Med 5:100058. https:\/\/doi.org\/10.1016\/j.amolm.2024.100058","journal-title":"Aspects Mol Med"},{"issue":"15_suppl","key":"6761_CR7","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.1200\/jco.2015.33.15_suppl.7003","volume":"33","author":"MJ Levis","year":"2015","unstructured":"Levis MJ, Perl AE, Altman JK, Cortes JE, Ritchie EK, Larson RA, Smith CC, Wang ES, Strickland SA, Baer MR, Litzow MR, Claxton D, Schiller GJ, Ustun C, Liu C, Gill S, Sargent B, Bahceci E (2015) Results of a first-in-human, phase I\/II trial of ASP2215, a selective, potent inhibitor of FLT3\/Axl in patients with relapsed or refractory (R\/R) acute myeloid leukemia (AML). J Clin Oncol 33(15_suppl):7003\u20137003. https:\/\/doi.org\/10.1200\/jco.2015.33.15_suppl.7003","journal-title":"J Clin Oncol"},{"issue":"2","key":"6761_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41375-018-0357-9","volume":"33","author":"N Daver","year":"2019","unstructured":"Daver N, Schlenk RF, Russell NH, Levis MJ (2019) Targeting FLT3 mutations in AML: review of current knowledge and evidence. Leukemia 33(2):299\u2013312. https:\/\/doi.org\/10.1038\/s41375-018-0357-9","journal-title":"Leukemia"},{"issue":"2","key":"6761_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/10428194.2013.800198","volume":"55","author":"S Kayser","year":"2014","unstructured":"Kayser S, Levis MJ (2014) FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations. Leuk Lymphoma 55(2):243\u2013255. https:\/\/doi.org\/10.3109\/10428194.2013.800198","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"6761_CR10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1177\/1947601910396505","volume":"1","author":"E Weisberg","year":"2010","unstructured":"Weisberg E, Roesel J, Furet P, Bold G, Imbach P, Florsheimer A, Caravatti G, Jiang J, Manley P, Ray A, Griffin JD (2010) Antileukemic effects of novel first- and second-generation FLT3 inhibitors: structure-affinity comparison. Genes Cancer 1(10):1021\u20131032. https:\/\/doi.org\/10.1177\/1947601910396505","journal-title":"Genes Cancer"},{"issue":"32","key":"6761_CR11","doi-asserted-by":"publisher","first-page":"52026","DOI":"10.18632\/oncotarget.19036","volume":"8","author":"EL Weisberg","year":"2017","unstructured":"Weisberg EL, Puissant A, Stone R, Sattler M, Buhrlage SJ, Yang J, Manley PW, Meng C, Buonopane M, Daley JF, Lazo S, Wright R, Weinstock DM, Christie AL, Stegmaier K, Griffin JD (2017) Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase. Oncotarget 8(32):52026\u201352044. https:\/\/doi.org\/10.18632\/oncotarget.19036","journal-title":"Oncotarget"},{"issue":"1","key":"6761_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0675-4","volume":"11","author":"M Wu","year":"2018","unstructured":"Wu M, Li C, Zhu X (2018) FLT3 inhibitors in acute myeloid leukemia. J Hematol Oncol 11(1):133. https:\/\/doi.org\/10.1186\/s13045-018-0675-4","journal-title":"J Hematol Oncol"},{"key":"6761_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vacun.2025.500391","author":"U Das","year":"2025","unstructured":"Das U, Banerjee S, Sarkar M (2025) Bibliometric analysis of circular RNA cancer vaccines and their emerging impact. Vacunas. https:\/\/doi.org\/10.1016\/j.vacun.2025.500391","journal-title":"Vacunas"},{"issue":"7","key":"6761_CR14","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41416-021-01527-2","volume":"125","author":"MU Tariq","year":"2021","unstructured":"Tariq MU, Furqan M, Parveen H, Ullah R, Muddassar M, Saleem RSZ, Bavetsias V, Linardopoulos S, Faisal A (2021) CCT245718, a dual FLT3\/Aurora A inhibitor overcomes D835Y-mediated resistance to FLT3 inhibitors in acute myeloid leukaemia cells. Br J Cancer 125(7):966\u2013974. https:\/\/doi.org\/10.1038\/s41416-021-01527-2","journal-title":"Br J Cancer"},{"key":"6761_CR15","doi-asserted-by":"publisher","unstructured":"Das U, Banerjee S, Sarkar M, Muhammad F, Kaur Soni T, Saha M, Pradhan G, Chatterjee B (2024)\u00a0 Circular RNA vaccines: pioneering the next-gen cancer immunotherapy [Internet]. [cited 2024 Dec 5]. Available from: \nhttps:\/\/www.preprints.org\/manuscript\/202409.2216\/v1. https:\/\/doi.org\/10.20944\/preprints202409.2216.v1","DOI":"10.20944\/preprints202409.2216.v1"},{"key":"6761_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2021.717141","volume":"1","author":"S Mahmud","year":"2021","unstructured":"Mahmud S, Hasan MdR, Biswas S, Paul GK, Afrose S, Mita MA, Sultana Shimu MstS, Promi MM, Hani U, Rahamathulla M, Khan MdA, Zaman S, Uddin MdS, Rahmatullah M, Jahan R, Alqahtani AM, Saleh MdA, Emran TB (2021) Screening of potent phytochemical inhibitors against SARS-CoV-2 main protease: an integrative computational approach. Front Bioinform 1:717141. https:\/\/doi.org\/10.3389\/fbinf.2021.717141","journal-title":"Front Bioinform"},{"key":"6761_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.sajb.2025.11.034","volume":"189","author":"MI Kumasagi","year":"2026","unstructured":"Kumasagi MI, Nagesha N, Dwivedi D, Santhosh GM, Hiremath S, Das U, Shankarappa KS (2026) Structure-based discovery of Saponarin as a broad-spectrum allosteric inhibitor of banana viral coat proteins. S Afr J Bot 189:191\u2013202. https:\/\/doi.org\/10.1016\/j.sajb.2025.11.034","journal-title":"S Afr J Bot"},{"issue":"1","key":"6761_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1208\/s12248-012-9322-0","volume":"14","author":"T Cheng","year":"2012","unstructured":"Cheng T, Li Q, Zhou Z, Wang Y, Bryant SH (2012) Structure-based virtual screening for drug discovery: a problem-centric review. AAPS J 14(1):133\u2013141. https:\/\/doi.org\/10.1208\/s12248-012-9322-0","journal-title":"AAPS J"},{"key":"6761_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.insi.2025.100006","author":"U Das","year":"2025","unstructured":"Das U, Uttarkar A, Kumar J, Niranjan V (2025) In silico exploration natural compounds for the discovery of novel dnmt3a inhibitors as potential therapeutic agents for acute myeloid leukaemia. In Silico Research in Biomedicine. https:\/\/doi.org\/10.1016\/j.insi.2025.100006","journal-title":"In Silico Research in Biomedicine"},{"issue":"2","key":"6761_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.drudis.2015.12.007","volume":"21","author":"A Lavecchia","year":"2016","unstructured":"Lavecchia A, Cerchia C (2016) In silico methods to address polypharmacology: current status, applications and future perspectives. Drug Discov Today 21(2):288\u2013298. https:\/\/doi.org\/10.1016\/j.drudis.2015.12.007","journal-title":"Drug Discov Today"},{"issue":"23","key":"6761_CR21","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.2174\/09298673113209990001","volume":"20","author":"A Lavecchia","year":"2013","unstructured":"Lavecchia A, Giovanni C (2013) Virtual screening strategies in drug discovery: a critical review. Curr Med Chem 20(23):2839\u20132860. https:\/\/doi.org\/10.2174\/09298673113209990001","journal-title":"Curr Med Chem"},{"issue":"5","key":"6761_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/bib\/bbp023","volume":"10","author":"CM Song","year":"2009","unstructured":"Song CM, Lim SJ, Tong JC (2009) Recent advances in computer-aided drug design. Brief Bioinform 10(5):579\u2013591. https:\/\/doi.org\/10.1093\/bib\/bbp023","journal-title":"Brief Bioinform"},{"issue":"7","key":"6761_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrd3480","volume":"10","author":"DC Swinney","year":"2011","unstructured":"Swinney DC, Anthony J (2011) How were new medicines discovered? Nat Rev Drug Discov 10(7):507\u2013519. https:\/\/doi.org\/10.1038\/nrd3480","journal-title":"Nat Rev Drug Discov"},{"key":"6761_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2025.100237","volume":"28","author":"ST Gopukumar","year":"2025","unstructured":"Gopukumar ST, Dwivedi D, Gowri K, Karpakavalli M, Nair C, Singh D, Das U (2025) Repurposing oncology drugs for Alzheimer\u2019s: multi-omic convergence targeting cell-cycle, proteostasis, immunometabolism, and senescence. Med Drug Discov 28:100237. https:\/\/doi.org\/10.1016\/j.medidd.2025.100237","journal-title":"Med Drug Discov"},{"issue":"16","key":"6761_CR25","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","volume":"14","author":"E Lionta","year":"2014","unstructured":"Lionta E, Spyrou G, Vassilatis DK, Cournia Z (2014) Structure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Top Med Chem 14(16):1923\u20131938. \nhttps:\/\/doi.org\/10.2174\/1568026614666140929124445","journal-title":"Curr Top Med Chem"},{"key":"6761_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2025.100213","volume":"27","author":"U Das","year":"2025","unstructured":"Das U (2025) Generative AI for drug discovery and protein design: the next frontier in AI-driven molecular science. Med Drug Discov 27:100213. https:\/\/doi.org\/10.1016\/j.medidd.2025.100213","journal-title":"Med Drug Discov"},{"issue":"36","key":"6761_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202502448","volume":"10","author":"U Das","year":"2025","unstructured":"Das U (2025) Transforming precision medicine through generative AI: advanced architectures and tailored therapeutic design for patient\u2010specific drug discovery. ChemistrySelect 10(36):e02448. https:\/\/doi.org\/10.1002\/slct.202502448","journal-title":"ChemistrySelect"},{"key":"6761_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.996438","volume":"12","author":"SS Ge","year":"2022","unstructured":"Ge SS, Liu SB, Xue SL (2022) Developments and challenges of FLT3 inhibitors in acute myeloid leukemia. Front Oncol 12:996438. https:\/\/doi.org\/10.3389\/fonc.2022.996438","journal-title":"Front Oncol"},{"issue":"4","key":"6761_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040927","volume":"12","author":"AB Hamid","year":"2020","unstructured":"Hamid AB, Petreaca RC (2020) Secondary resistant mutations to small molecule inhibitors in cancer cells. Cancers 12(4):927. \nhttps:\/\/doi.org\/10.3390\/cancers12040927","journal-title":"Cancers"},{"issue":"1","key":"6761_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00992-1","volume":"13","author":"MT Gebru","year":"2020","unstructured":"Gebru MT, Wang HG (2020) Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia. J Hematol Oncol 13(1):155. https:\/\/doi.org\/10.1186\/s13045-020-00992-1","journal-title":"J Hematol Oncol"},{"issue":"12","key":"6761_CR31","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","volume":"60","author":"JJ Irwin","year":"2020","unstructured":"Irwin JJ, Tang KG, Young J, Dandarchuluun C, Wong BR, Khurelbaatar M, Moroz YS, Mayfield J, Sayle RA (2020) ZINC20\u2014a free ultralarge-scale chemical database for ligand discovery. J Chem Inf Model 60(12):6065\u20136073. https:\/\/doi.org\/10.1021\/acs.jcim.0c00675","journal-title":"J Chem Inf Model"},{"issue":"Database issue","key":"6761_CR32","doi-asserted-by":"publisher","first-page":"D198","DOI":"10.1093\/nar\/gkl999","volume":"35","author":"T Liu","year":"2007","unstructured":"Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK (2007) BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res 35(Database issue):D198-201. \nhttps:\/\/doi.org\/10.1093\/nar\/gkl999","journal-title":"Nucleic Acids Res"},{"key":"6761_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2025.108427","volume":"117","author":"U Das","year":"2025","unstructured":"Das U, Chanda T, Kumar J, Peter A (2025) Discovery of natural MCL1 inhibitors using pharmacophore modelling, QSAR, docking, ADMET, molecular dynamics, and DFT analysis. Comput Biol Chem 117:108427. https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108427","journal-title":"Comput Biol Chem"},{"issue":"1","key":"6761_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-025-01005-y","volume":"26","author":"U Das","year":"2025","unstructured":"Das U, Mukherjee A, Mukunthan KS, Kumar J (2025) Identification of potential natural BCL-2 inhibitors for leukemia through an integrated virtual screening approach. BMC Pharmacol Toxicol 26(1):176. https:\/\/doi.org\/10.1186\/s40360-025-01005-y","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1\u20133","key":"6761_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1\u20133):3\u201326. https:\/\/doi.org\/10.1016\/S0169-409X(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"6761_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM (2000) The Protein Data Bank. Nucleic Acids Res 28(1):235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"issue":"58","key":"6761_CR37","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.18632\/oncotarget.27222","volume":"10","author":"T Kawase","year":"2019","unstructured":"Kawase T, Nakazawa T, Eguchi T, Tsuzuki H, Ueno Y, Amano Y, Suzuki T, Mori M, Yoshida T (2019) Effect of fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of Gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells. Oncotarget 10(58):6111\u20136123. https:\/\/doi.org\/10.18632\/oncotarget.27222)","journal-title":"Oncotarget"},{"issue":"8","key":"6761_CR38","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1039\/D1SC05610G","volume":"13","author":"H Gokcan","year":"2022","unstructured":"Gokcan H, Isayev O (2022) Prediction of protein p Ka with representation learning. Chem Sci 13(8):2462\u20132474. https:\/\/doi.org\/10.1039\/D1SC05610G","journal-title":"Chem Sci"},{"issue":"17","key":"6761_CR39","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1021\/acs.jcim.2c00735","volume":"62","author":"SJ Mahdizadeh","year":"2022","unstructured":"Mahdizadeh SJ, P\u00e5lsson E, Carlesso A, Chevet E, Eriksson LA (2022) QM\/MM well-tempered metadynamics study of the mechanism of XBP1 mRNA cleavage by Inositol Requiring Enzyme 1\u03b1 RNase. J Chem Inf Model 62(17):4247\u20134260. https:\/\/doi.org\/10.1021\/acs.jcim.2c00735","journal-title":"J Chem Inf Model"},{"issue":"21","key":"6761_CR40","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision Glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes. J Med Chem 49(21):6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o","journal-title":"J Med Chem"},{"key":"6761_CR41","doi-asserted-by":"publisher","unstructured":"Stradiotto M, Lundgren RJ (ed) (2016) Ligand design in metal chemistry: reactivity and catalysis [Internet]. 1st ed. Wiley. [cited 2025 Mar 4]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/book\/10.1002\/9781118839621.\u00a0https:\/\/doi.org\/10.1002\/9781118839621","DOI":"10.1002\/9781118839621"},{"issue":"5","key":"6761_CR42","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2174\/1573409919666230123144712","volume":"19","author":"A Mahor","year":"2023","unstructured":"Mahor A, Sawant DM, Goyal AK (2023) The custom R group enumeration with various R group libraries at designated sites on Amphotericin B. Curr Comput Aided Drug Des 19(5):382\u2013390. https:\/\/doi.org\/10.2174\/1573409919666230123144712","journal-title":"Curr Comput Aided Drug Des"},{"issue":"1","key":"6761_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"issue":"W1","key":"6761_CR44","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee P, Kemmler E, Dunkel M, Preissner R (2024) ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 52(W1):W513\u2013W520. https:\/\/doi.org\/10.1093\/nar\/gkae303","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"6761_CR45","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L, Shi S, Yi J, Wang N, He Y, Wu Z, Peng J, Deng Y, Wang W, Wu C, Lyu A, Zeng X, Zhao W, Hou T, Cao D (2024) ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res 52(W1):W422\u2013W431. https:\/\/doi.org\/10.1093\/nar\/gkae236","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"6761_CR46","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58(9):4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"issue":"9","key":"6761_CR47","doi-asserted-by":"publisher","first-page":"11407","DOI":"10.1021\/acsomega.8b01524","volume":"3","author":"L Ivanova","year":"2018","unstructured":"Ivanova L, Tammiku-Taul J, Garc\u00eda-Sosa AT, Sidorova Y, Saarma M, Karelson M (2018) Molecular dynamics simulations of the interactions between glial cell line-derived neurotrophic factor family receptor GFR\u03b11 and small-molecule ligands. ACS Omega 3(9):11407\u201311414. https:\/\/doi.org\/10.1021\/acsomega.8b01524","journal-title":"ACS Omega"},{"issue":"7","key":"6761_CR48","doi-asserted-by":"publisher","DOI":"10.1063\/1.4960175","volume":"145","author":"S Izadi","year":"2016","unstructured":"Izadi S, Onufriev AV (2016) Accuracy limit of rigid 3-point water models. J Chem Phys 145(7):074501. https:\/\/doi.org\/10.1063\/1.4960175","journal-title":"J Chem Phys"},{"issue":"7","key":"6761_CR49","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W, Ross GA, Dahlgren MK, Russell E, Von Bargen CD, Abel R, Friesner RA, Harder ED (2021) OPLS4: improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput 17(7):4291\u20134300. https:\/\/doi.org\/10.1021\/acs.jctc.1c00302","journal-title":"J Chem Theory Comput"},{"issue":"3","key":"6761_CR50","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/07391102.2021.2011785","volume":"41","author":"MHA Al-Jumaili","year":"2023","unstructured":"Al-Jumaili MHA, Siddique F, AbulQais F, Hashem HE, Chtita S, Rani A, Uzair M, Almzaien KA (2023) Analysis and prediction pathways of natural products and their cytotoxicity against HeLa cell line protein using docking, molecular dynamics and ADMET. J Biomol Struct Dyn 41(3):765\u2013777. https:\/\/doi.org\/10.1080\/07391102.2021.2011785","journal-title":"J Biomol Struct Dyn"},{"issue":"3","key":"6761_CR51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD (2007) Matplotlib: a 2D graphics environment. Comput Sci Eng 9(3):90\u201395. https:\/\/doi.org\/10.1109\/MCSE.2007.55","journal-title":"Comput Sci Eng"},{"issue":"10","key":"6761_CR52","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/prot.23106","volume":"79","author":"J Li","year":"2011","unstructured":"Li J, Abel R, Zhu K, Cao Y, Zhao S, Friesner RA (2011) The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling. Proteins 79(10):2794\u20132812. https:\/\/doi.org\/10.1002\/prot.23106","journal-title":"Proteins"},{"issue":"16","key":"6761_CR53","doi-asserted-by":"publisher","first-page":"7712","DOI":"10.1080\/07391102.2022.2123403","volume":"41","author":"M Ouassaf","year":"2023","unstructured":"Ouassaf M, Daoui O, Alam S, Elkhattabi S, Belaidi S, Chtita S (2023) Pharmacophore-based virtual screening, molecular docking, and molecular dynamics studies for the discovery of novel FLT3 inhibitors. J Biomol Struct Dyn 41(16):7712\u20137724. https:\/\/doi.org\/10.1080\/07391102.2022.2123403","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"6761_CR54","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2018","unstructured":"Laskowski RA, Jab\u0142o\u0144ska J, Pravda L, Va\u0159ekov\u00e1 RS, Thornton JM (2018) PDBsum: structural summaries of PDB entries. Protein Sci 27(1):129\u2013134. https:\/\/doi.org\/10.1002\/pro.3289","journal-title":"Protein Sci"},{"issue":"1","key":"6761_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0022-2836(63)80023-6","volume":"7","author":"GN Ramachandran","year":"1963","unstructured":"Ramachandran GN, Ramakrishnan C, Sasisekharan V (1963) Stereochemistry of polypeptide chain configurations. J Mol Biol 7(1):95\u201399. https:\/\/doi.org\/10.1016\/S0022-2836(63)80023-6","journal-title":"J Mol Biol"},{"issue":"5","key":"6761_CR56","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.bmc.2019.01.006","volume":"27","author":"SH Grimm","year":"2019","unstructured":"Grimm SH, Gagestein B, Keijzer JF, Liu N, Wijdeven RH, Lenselink EB, Tuin AW, Van Den Nieuwendijk AMCH, Van Westen GJP, Van Boeckel CAA, Overkleeft HS, Neefjes J, Van Der Stelt M (2019) Comprehensive structure-activity-relationship of azaindoles as highly potent FLT3 inhibitors. Bioorg Med Chem 27(5):692\u2013699. https:\/\/doi.org\/10.1016\/j.bmc.2019.01.006","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"6761_CR57","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.bmcl.2015.03.043","volume":"25","author":"WT McElroy","year":"2015","unstructured":"McElroy WT, Seganish MW, Herr JR, Harding J, Yang J, Yet L, Komanduri V, Prakash KC, Lavey B, Tulshian D, Greenlee WJ, Sondey C, Fischmann TO, Niu X (2015) Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4. Bioorg Med Chem Lett 25(9):1836\u20131841. https:\/\/doi.org\/10.1016\/j.bmcl.2015.03.043","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"6761_CR58","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1097-2765(03)00505-7","volume":"13","author":"J Griffith","year":"2004","unstructured":"Griffith J, Black J, Faerman C, Swenson L, Wynn M, Lu F, Lippke J, Saxena K (2004) The structural basis for autoinhibition of FLT3 by the juxtamembrane domain. Mol Cell 13(2):169\u2013178. https:\/\/doi.org\/10.1016\/S1097-2765(03)00505-7","journal-title":"Mol Cell"},{"key":"6761_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/4170703","volume":"2023","author":"A Abdullah","year":"2023","unstructured":"Abdullah A, Biswas P, Sahabuddin M, Mubasharah A, Khan DA, Hossain A, Roy T, Rafi NMdR., Dey D, Hasan MdN., Bibi S, Moustafa M, Shati A, Hassan H, Garg R (2023) Molecular dynamics simulation and pharmacoinformatic integrated analysis of bioactive phytochemicals from Azadirachta indica (Neem) to treat diabetes mellitus. J Chem 2023:1\u201319. https:\/\/doi.org\/10.1155\/2023\/4170703","journal-title":"J Chem"},{"issue":"12","key":"6761_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121617","volume":"17","author":"AM Hassan","year":"2024","unstructured":"Hassan AM, Gattan HS, Faizo AA, Alruhaili MH, Alharbi AS, Bajrai LH, AL-Zahrani IA, Dwivedi VD, Azhar EI (2024) Evaluating the binding potential and stability of drug-like compounds with the Monkeypox Virus VP39 protein using molecular dynamics simulations and free energy analysis. Pharmaceuticals 17(12):1617. https:\/\/doi.org\/10.3390\/ph17121617","journal-title":"Pharmaceuticals"},{"issue":"12","key":"6761_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111368","volume":"27","author":"M Shi","year":"2024","unstructured":"Shi M, Wang F, Lu Z, Yin Y, Zheng X, Wang D, Cai X, Jing M, Wang J, Chen J, Jiang X, Yu W, Li X (2024) Elucidating the linagliptin and fibroblast activation protein binding mechanism through molecular dynamics and binding free energy analysis. iScience 27(12):111368. https:\/\/doi.org\/10.1016\/j.isci.2024.111368","journal-title":"iScience"},{"key":"6761_CR62","doi-asserted-by":"publisher","DOI":"10.1177\/11779322251399077","volume":"19","author":"U Das","year":"2025","unstructured":"Das U, Regati DR, Kumar J, Sowdhamini R (2025) Exploration of natural products for targeting IDH1\/2 mutations in acute myeloid leukemia through ligand-based pharmacophore screening, docking, ADME-T, and molecular dynamic simulation approaches. Bioinforma Biol Insights 19:11779322251399077. https:\/\/doi.org\/10.1177\/11779322251399077","journal-title":"Bioinforma Biol Insights"},{"issue":"1","key":"6761_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4672","volume":"5","author":"Y Kang","year":"2014","unstructured":"Kang Y, Tiziani S, Park G, Kaul M, Paternostro G (2014) Cellular protection using Flt3 and PI3K\u03b1 inhibitors demonstrates multiple mechanisms of oxidative glutamate toxicity. Nat Commun 5(1):3672. https:\/\/doi.org\/10.1038\/ncomms4672","journal-title":"Nat Commun"},{"issue":"8","key":"6761_CR64","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1038\/bcj.2013.40","volume":"3","author":"M Kesarwani","year":"2013","unstructured":"Kesarwani M, Huber E, Azam M (2013Aug 30) Overcoming AC220 resistance of FLT3-ITD by SAR302503. Blood Cancer J 3(8):e138\u2013e138. https:\/\/doi.org\/10.1038\/bcj.2013.40","journal-title":"Blood Cancer J"},{"key":"6761_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1511257","volume":"16","author":"K Shi","year":"2025","unstructured":"Shi K, Hong Y, Liu H, Yang X, Wang F, Zhang Y (2025) Discovery of novel and highly potent small molecule inhibitors targeting FLT3-ITD for the treatment of acute myeloid leukemia using structure-based virtual screening and biological evaluation. Front Pharmacol 16:1511257. https:\/\/doi.org\/10.3389\/fphar.2025.1511257","journal-title":"Front Pharmacol"},{"issue":"1","key":"6761_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1258","volume":"2","author":"M Ahmad","year":"2011","unstructured":"Ahmad M, Gu W, Geyer T, Helms V (2011) Adhesive water networks facilitate binding of protein interfaces. Nat Commun 2(1):261. https:\/\/doi.org\/10.1038\/ncomms1258","journal-title":"Nat Commun"},{"issue":"11","key":"6761_CR67","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1080\/17460441.2021.1933427","volume":"16","author":"P Richardson","year":"2021","unstructured":"Richardson P (2021) Applications of fluorine to the construction of bioisosteric elements for the purposes of novel drug discovery. Expert Opin Drug Discov 16(11):1261\u20131286. https:\/\/doi.org\/10.1080\/17460441.2021.1933427","journal-title":"Expert Opin Drug Discov"},{"issue":"23","key":"6761_CR68","doi-asserted-by":"publisher","first-page":"10602","DOI":"10.1021\/acs.jmedchem.8b01222","volume":"61","author":"B Jeffries","year":"2018","unstructured":"Jeffries B, Wang Z, Graton J, Holland SD, Brind T, Greenwood RDR, Le Questel JY, Scott JS, Chiarparin E, Linclau B (2018) Reducing the lipophilicity of perfluoroalkyl groups by CF2 \u2013F\/CF2 \u2013Me or CF3 \/CH3 exchange. J Med Chem 61(23):10602\u201310618. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01222","journal-title":"J Med Chem"},{"issue":"3","key":"6761_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ph17030281","volume":"17","author":"E Henary","year":"2024","unstructured":"Henary E, Casa S, Dost TL, Sloop JC, Henary M (2024) The role of small molecules containing fluorine atoms in medicine and imaging applications. Pharm Basel Switz 17(3):281. https:\/\/doi.org\/10.3390\/ph17030281","journal-title":"Pharm Basel Switz"},{"issue":"9","key":"6761_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202200020","volume":"17","author":"MR van der Kolk","year":"2022","unstructured":"van der Kolk MR, Janssen MACH, Rutjes FPJT, Blanco-Ania D (2022) Cyclobutanes in small-molecule drug candidates. ChemMedChem 17(9):e202200020. https:\/\/doi.org\/10.1002\/cmdc.202200020","journal-title":"ChemMedChem"},{"issue":"24","key":"6761_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232416169","volume":"23","author":"M Tomanov\u00e1","year":"2022","unstructured":"Tomanov\u00e1 M, Kozlansk\u00e1 K, Jorda R, Jedin\u00e1k L, Havl\u00edkov\u00e1 T, \u0158ezn\u00ed\u010dkov\u00e1 E, Pe\u0159ina M, Klener P, Doln\u00edkov\u00e1 A, Canka\u0159 P, Kry\u0161tof V (2022) Synthesis and structural optimization of 2,7,9-trisubstituted purin-8-ones as FLT3-ITD inhibitors. Int J Mol Sci 23(24):16169. https:\/\/doi.org\/10.3390\/ijms232416169","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6761_CR72","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.bpj.2020.08.005","volume":"119","author":"C Tse","year":"2020","unstructured":"Tse C, Wickstrom L, Kvaratskhelia M, Gallicchio E, Levy R, Deng N (2020) Exploring the free-energy landscape and thermodynamics of protein-protein association. Biophys J 119(6):1226\u201338. https:\/\/doi.org\/10.1016\/j.bpj.2020.08.005","journal-title":"Biophys J"},{"issue":"6","key":"6761_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-025-10194-2","volume":"20","author":"S Debnath","year":"2025","unstructured":"Debnath S, Das U, Uttarkar A, Niranjan V, De A (2025) In silico discovery of Tanshinone I, a diterpenoid from Salvia miltiorrhiza (Danshen), as a dual antiviral natural inhibitor targeting conserved allosteric sites of HMPV and HRSV RNA-dependent RNA polymerases. J Pharm Innov 20(6):305. https:\/\/doi.org\/10.1007\/s12247-025-10194-2","journal-title":"J Pharm Innov"},{"issue":"10","key":"6761_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0334415","volume":"20","author":"B Budha","year":"2025","unstructured":"Budha B, Basu Choudhury G, Hossain MS, Acharya A (2025) Structure-guided discovery and characterization of novel FLT3 inhibitors for acute myeloid leukemia treatment. PloS One 20(10):e0334415. https:\/\/doi.org\/10.1371\/journal.pone.0334415","journal-title":"PloS One"},{"key":"6761_CR75","doi-asserted-by":"publisher","DOI":"10.34133\/research.0747","volume":"8","author":"S Baldi","year":"2025","unstructured":"Baldi S, Long N, Ma S, Liu L, Al-Danakh A, Yang Q, Deng X, Xie J, Tang H (2025) Advancements in protein kinase inhibitors: from discovery to clinical applications. Research 8:0747. https:\/\/doi.org\/10.34133\/research.0747","journal-title":"Research"},{"issue":"20","key":"6761_CR76","doi-asserted-by":"publisher","first-page":"11367","DOI":"10.1073\/pnas.1831920100","volume":"100","author":"F Takagi","year":"2003","unstructured":"Takagi F, Koga N, Takada S (2003) How protein thermodynamics and folding mechanisms are altered by the chaperonin cage: molecular simulations. Proc Natl Acad Sci U S A 100(20):11367\u201311372. https:\/\/doi.org\/10.1073\/pnas.1831920100","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-026-06761-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-026-06761-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-026-06761-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:04:29Z","timestamp":1780437869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-026-06761-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["6761"],"URL":"https:\/\/doi.org\/10.1007\/s00894-026-06761-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7508862\/v1","asserted-by":"object"}]},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not involve any human participants or animal subjects, and therefore, no ethical approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The writing of this research paper involved the use of generative AI and AI-assisted technologies only to enhance the clarity, coherence, and overall quality of the manuscript. The authors acknowledge the contributions of AI in the writing process while ensuring that the final content reflects the author\u2019s own insights and interpretations of the literature. All interpretations and conclusions drawn in this manuscript are the sole responsibility of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}],"article-number":"191"}}